- Motley Fool•5 days ago
Does Opko Health's recent clinical setback hurt it in a head-to-head comparison with Qiagen? Or does it actually help?
- Investopedia•8 days ago
After a disappointing 2016, Opko hopes to spring back with solid objectives set for 2017.
- Motley Fool•11 days ago
Opko Health talks about its momentum and a second chance for its human growth hormone at the J. P. Morgan Healthcare Conference.
OPK : Summary for Opko Health, Inc. - Yahoo Finance
Opko Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||8.48 x 1100|
|Ask||8.49 x 1900|
|Day's Range||8.43 - 8.62|
|52 Week Range||7.42 - 12.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||35.42|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|